Phase IV / Post-Market CROs
Post-marketing surveillance, real-world evidence generation, and label expansion studies.
4 organizations offer this service
ICON plc
FeaturedGlobal provider of outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. ICON specializes in clinical research with operations across 53 countries.
Syneos Health
FeaturedIntegrated biopharmaceutical solutions company combining clinical development and commercial capabilities. Syneos offers end-to-end solutions from Phase I through product launch and beyond.
PPD (Thermo Fisher Scientific)
FeaturedA leading global contract research organization acquired by Thermo Fisher Scientific. PPD provides comprehensive clinical development services including laboratory, data management, and regulatory services.
PRA Health Sciences (ICON)
Global CRO acquired by ICON in 2021. Provides full-service clinical development, data management, and strategic consulting across all major therapeutic areas.